Global Hepatitis Delta Virus (HDV) Infection Market Growth (Status and Outlook) 2026-2032
The global Hepatitis Delta Virus (HDV) Infection market size is predicted to grow from US$ 2013 million in 2025 to US$ 13010 million in 2032; it is expected to grow at a CAGR of 31.1% from 2026 to 2032.
Hepatitis D, also known as delta hepatitis, is a liver infection caused by the Hepatitis D virus (HDV). It is considered a satellite virus, as it requires the presence of the Hepatitis B virus (HBV) to replicate and cause infection. HDV infects individuals either as a co-infection with HBV or as a superinfection in those already infected with HBV. Hepatitis D is caused by the HDV, which can only infect individuals already infected with HBV. HDV can spread through contact with infected blood or body fluids, similar to HBV transmission routes. Injection drug use, exposure to infected blood, or unprotected sexual contact with an HBV/HDV-infected person are common risk factors for acquiring Hepatitis D.
The increasing global prevalence of HDV infection is a significant market driver that is boosting the Market CAGR. HDV infection, which occurs along with hepatitis B virus (HBV) infection, is considered the most severe form of viral hepatitis, resulting in increased morbidity and fatality rates. The World Health Organization (WHO) estimates that over 15-20 million people globally are chronically infected with HDV. This growing incidence of HDV infection highlights the critical need for improved diagnoses, therapies, and preventive measures, which will drive market expansion.
LPI (LP Information)' newest research report, the ?Hepatitis Delta Virus (HDV) Infection Industry Forecast? looks at past sales and reviews total world Hepatitis Delta Virus (HDV) Infection sales in 2025, providing a comprehensive analysis by region and market sector of projected Hepatitis Delta Virus (HDV) Infection sales for 2026 through 2032. With Hepatitis Delta Virus (HDV) Infection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hepatitis Delta Virus (HDV) Infection industry.
This Insight Report provides a comprehensive analysis of the global Hepatitis Delta Virus (HDV) Infection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Hepatitis Delta Virus (HDV) Infection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Hepatitis Delta Virus (HDV) Infection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hepatitis Delta Virus (HDV) Infection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hepatitis Delta Virus (HDV) Infection.
This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis Delta Virus (HDV) Infection market by product type, application, key players and key regions and countries.
Segmentation by Type:
Hepatitis D, also known as delta hepatitis, is a liver infection caused by the Hepatitis D virus (HDV). It is considered a satellite virus, as it requires the presence of the Hepatitis B virus (HBV) to replicate and cause infection. HDV infects individuals either as a co-infection with HBV or as a superinfection in those already infected with HBV. Hepatitis D is caused by the HDV, which can only infect individuals already infected with HBV. HDV can spread through contact with infected blood or body fluids, similar to HBV transmission routes. Injection drug use, exposure to infected blood, or unprotected sexual contact with an HBV/HDV-infected person are common risk factors for acquiring Hepatitis D.
The increasing global prevalence of HDV infection is a significant market driver that is boosting the Market CAGR. HDV infection, which occurs along with hepatitis B virus (HBV) infection, is considered the most severe form of viral hepatitis, resulting in increased morbidity and fatality rates. The World Health Organization (WHO) estimates that over 15-20 million people globally are chronically infected with HDV. This growing incidence of HDV infection highlights the critical need for improved diagnoses, therapies, and preventive measures, which will drive market expansion.
LPI (LP Information)' newest research report, the ?Hepatitis Delta Virus (HDV) Infection Industry Forecast? looks at past sales and reviews total world Hepatitis Delta Virus (HDV) Infection sales in 2025, providing a comprehensive analysis by region and market sector of projected Hepatitis Delta Virus (HDV) Infection sales for 2026 through 2032. With Hepatitis Delta Virus (HDV) Infection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hepatitis Delta Virus (HDV) Infection industry.
This Insight Report provides a comprehensive analysis of the global Hepatitis Delta Virus (HDV) Infection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Hepatitis Delta Virus (HDV) Infection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Hepatitis Delta Virus (HDV) Infection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hepatitis Delta Virus (HDV) Infection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hepatitis Delta Virus (HDV) Infection.
This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis Delta Virus (HDV) Infection market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Acute Hepatitis D
- Chronic Hepatitis D
- Clinic
- Hospital
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BIOSIDUS
- Hoffmann-La Roche Ltd.
- Zydus Cadila
- NanoGen Healthcare Pvt. Ltd.
- AMEGA Biotech
- Rhein-Minapharm
- PROBIOMED SA de CV
- 3SBio Group
- Eiger BioPharmaceuticals
- Arrowhead Pharmaceuticals, Inc
- MYR Pharmaceuticals
- Hepatera
- Janssen Biopharmaceuticals
- Antios Therapeutics, Inc.
- PharmaEssentia Corporation
- Replicor, Janssen Pharmaceuticals, Inc
- Apotex Corp.
- Mylan N.V
- Aurobindo Pharma Limited
- Gilead Sciences, Inc.
- GlaxoSmithKline
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hepatitis Delta Virus (HDV) Infection Market Size (2021-2032)
2.1.2 Hepatitis Delta Virus (HDV) Infection Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Hepatitis Delta Virus (HDV) Infection by Country/Region (2021, 2025 & 2032)
2.2 Hepatitis Delta Virus (HDV) Infection Segment by Type
2.2.1 Acute Hepatitis D
2.2.2 Chronic Hepatitis D
2.2.3 Hepatitis Delta Virus (HDV) Infection Market Size by Type
2.2.3.1 Hepatitis Delta Virus (HDV) Infection Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Type (2021-2026)
2.3 Hepatitis Delta Virus (HDV) Infection Segment by Application
2.3.1 Clinic
2.3.2 Hospital
2.3.3 Others
2.3.4 Hepatitis Delta Virus (HDV) Infection Market Size by Application
2.3.4.1 Hepatitis Delta Virus (HDV) Infection Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Application (2021-2026)
3 HEPATITIS DELTA VIRUS (HDV) INFECTION MARKET SIZE BY PLAYER
3.1 Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Player
3.1.1 Global Hepatitis Delta Virus (HDV) Infection Revenue by Player (2021-2026)
3.1.2 Global Hepatitis Delta Virus (HDV) Infection Revenue Market Share by Player (2021-2026)
3.2 Global Hepatitis Delta Virus (HDV) Infection Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HEPATITIS DELTA VIRUS (HDV) INFECTION BY REGION
4.1 Hepatitis Delta Virus (HDV) Infection Market Size by Region (2021-2026)
4.2 Global Hepatitis Delta Virus (HDV) Infection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Hepatitis Delta Virus (HDV) Infection Market Size Growth (2021-2026)
4.4 APAC Hepatitis Delta Virus (HDV) Infection Market Size Growth (2021-2026)
4.5 Europe Hepatitis Delta Virus (HDV) Infection Market Size Growth (2021-2026)
4.6 Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Hepatitis Delta Virus (HDV) Infection Market Size by Country (2021-2026)
5.2 Americas Hepatitis Delta Virus (HDV) Infection Market Size by Type (2021-2026)
5.3 Americas Hepatitis Delta Virus (HDV) Infection Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hepatitis Delta Virus (HDV) Infection Market Size by Region (2021-2026)
6.2 APAC Hepatitis Delta Virus (HDV) Infection Market Size by Type (2021-2026)
6.3 APAC Hepatitis Delta Virus (HDV) Infection Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Hepatitis Delta Virus (HDV) Infection Market Size by Country (2021-2026)
7.2 Europe Hepatitis Delta Virus (HDV) Infection Market Size by Type (2021-2026)
7.3 Europe Hepatitis Delta Virus (HDV) Infection Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hepatitis Delta Virus (HDV) Infection by Region (2021-2026)
8.2 Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size by Type (2021-2026)
8.3 Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HEPATITIS DELTA VIRUS (HDV) INFECTION MARKET FORECAST
10.1 Global Hepatitis Delta Virus (HDV) Infection Forecast by Region (2027-2032)
10.1.1 Global Hepatitis Delta Virus (HDV) Infection Forecast by Region (2027-2032)
10.1.2 Americas Hepatitis Delta Virus (HDV) Infection Forecast
10.1.3 APAC Hepatitis Delta Virus (HDV) Infection Forecast
10.1.4 Europe Hepatitis Delta Virus (HDV) Infection Forecast
10.1.5 Middle East & Africa Hepatitis Delta Virus (HDV) Infection Forecast
10.2 Americas Hepatitis Delta Virus (HDV) Infection Forecast by Country (2027-2032)
10.2.1 United States Market Hepatitis Delta Virus (HDV) Infection Forecast
10.2.2 Canada Market Hepatitis Delta Virus (HDV) Infection Forecast
10.2.3 Mexico Market Hepatitis Delta Virus (HDV) Infection Forecast
10.2.4 Brazil Market Hepatitis Delta Virus (HDV) Infection Forecast
10.3 APAC Hepatitis Delta Virus (HDV) Infection Forecast by Region (2027-2032)
10.3.1 China Hepatitis Delta Virus (HDV) Infection Market Forecast
10.3.2 Japan Market Hepatitis Delta Virus (HDV) Infection Forecast
10.3.3 Korea Market Hepatitis Delta Virus (HDV) Infection Forecast
10.3.4 Southeast Asia Market Hepatitis Delta Virus (HDV) Infection Forecast
10.3.5 India Market Hepatitis Delta Virus (HDV) Infection Forecast
10.3.6 Australia Market Hepatitis Delta Virus (HDV) Infection Forecast
10.4 Europe Hepatitis Delta Virus (HDV) Infection Forecast by Country (2027-2032)
10.4.1 Germany Market Hepatitis Delta Virus (HDV) Infection Forecast
10.4.2 France Market Hepatitis Delta Virus (HDV) Infection Forecast
10.4.3 UK Market Hepatitis Delta Virus (HDV) Infection Forecast
10.4.4 Italy Market Hepatitis Delta Virus (HDV) Infection Forecast
10.4.5 Russia Market Hepatitis Delta Virus (HDV) Infection Forecast
10.5 Middle East & Africa Hepatitis Delta Virus (HDV) Infection Forecast by Region (2027-2032)
10.5.1 Egypt Market Hepatitis Delta Virus (HDV) Infection Forecast
10.5.2 South Africa Market Hepatitis Delta Virus (HDV) Infection Forecast
10.5.3 Israel Market Hepatitis Delta Virus (HDV) Infection Forecast
10.5.4 Turkey Market Hepatitis Delta Virus (HDV) Infection Forecast
10.6 Global Hepatitis Delta Virus (HDV) Infection Forecast by Type (2027-2032)
10.7 Global Hepatitis Delta Virus (HDV) Infection Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Hepatitis Delta Virus (HDV) Infection Forecast
11 KEY PLAYERS ANALYSIS
11.1 BIOSIDUS
11.1.1 BIOSIDUS Company Information
11.1.2 BIOSIDUS Hepatitis Delta Virus (HDV) Infection Product Offered
11.1.3 BIOSIDUS Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 BIOSIDUS Main Business Overview
11.1.5 BIOSIDUS Latest Developments
11.2 Hoffmann-La Roche Ltd.
11.2.1 Hoffmann-La Roche Ltd. Company Information
11.2.2 Hoffmann-La Roche Ltd. Hepatitis Delta Virus (HDV) Infection Product Offered
11.2.3 Hoffmann-La Roche Ltd. Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Hoffmann-La Roche Ltd. Main Business Overview
11.2.5 Hoffmann-La Roche Ltd. Latest Developments
11.3 Zydus Cadila
11.3.1 Zydus Cadila Company Information
11.3.2 Zydus Cadila Hepatitis Delta Virus (HDV) Infection Product Offered
11.3.3 Zydus Cadila Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Zydus Cadila Main Business Overview
11.3.5 Zydus Cadila Latest Developments
11.4 NanoGen Healthcare Pvt. Ltd.
11.4.1 NanoGen Healthcare Pvt. Ltd. Company Information
11.4.2 NanoGen Healthcare Pvt. Ltd. Hepatitis Delta Virus (HDV) Infection Product Offered
11.4.3 NanoGen Healthcare Pvt. Ltd. Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 NanoGen Healthcare Pvt. Ltd. Main Business Overview
11.4.5 NanoGen Healthcare Pvt. Ltd. Latest Developments
11.5 AMEGA Biotech
11.5.1 AMEGA Biotech Company Information
11.5.2 AMEGA Biotech Hepatitis Delta Virus (HDV) Infection Product Offered
11.5.3 AMEGA Biotech Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 AMEGA Biotech Main Business Overview
11.5.5 AMEGA Biotech Latest Developments
11.6 Rhein-Minapharm
11.6.1 Rhein-Minapharm Company Information
11.6.2 Rhein-Minapharm Hepatitis Delta Virus (HDV) Infection Product Offered
11.6.3 Rhein-Minapharm Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Rhein-Minapharm Main Business Overview
11.6.5 Rhein-Minapharm Latest Developments
11.7 PROBIOMED SA de CV
11.7.1 PROBIOMED SA de CV Company Information
11.7.2 PROBIOMED SA de CV Hepatitis Delta Virus (HDV) Infection Product Offered
11.7.3 PROBIOMED SA de CV Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 PROBIOMED SA de CV Main Business Overview
11.7.5 PROBIOMED SA de CV Latest Developments
11.8 3SBio Group
11.8.1 3SBio Group Company Information
11.8.2 3SBio Group Hepatitis Delta Virus (HDV) Infection Product Offered
11.8.3 3SBio Group Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 3SBio Group Main Business Overview
11.8.5 3SBio Group Latest Developments
11.9 Eiger BioPharmaceuticals
11.9.1 Eiger BioPharmaceuticals Company Information
11.9.2 Eiger BioPharmaceuticals Hepatitis Delta Virus (HDV) Infection Product Offered
11.9.3 Eiger BioPharmaceuticals Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Eiger BioPharmaceuticals Main Business Overview
11.9.5 Eiger BioPharmaceuticals Latest Developments
11.10 Arrowhead Pharmaceuticals, Inc
11.10.1 Arrowhead Pharmaceuticals, Inc Company Information
11.10.2 Arrowhead Pharmaceuticals, Inc Hepatitis Delta Virus (HDV) Infection Product Offered
11.10.3 Arrowhead Pharmaceuticals, Inc Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Arrowhead Pharmaceuticals, Inc Main Business Overview
11.10.5 Arrowhead Pharmaceuticals, Inc Latest Developments
11.11 MYR Pharmaceuticals
11.11.1 MYR Pharmaceuticals Company Information
11.11.2 MYR Pharmaceuticals Hepatitis Delta Virus (HDV) Infection Product Offered
11.11.3 MYR Pharmaceuticals Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 MYR Pharmaceuticals Main Business Overview
11.11.5 MYR Pharmaceuticals Latest Developments
11.12 Hepatera
11.12.1 Hepatera Company Information
11.12.2 Hepatera Hepatitis Delta Virus (HDV) Infection Product Offered
11.12.3 Hepatera Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Hepatera Main Business Overview
11.12.5 Hepatera Latest Developments
11.13 Janssen Biopharmaceuticals
11.13.1 Janssen Biopharmaceuticals Company Information
11.13.2 Janssen Biopharmaceuticals Hepatitis Delta Virus (HDV) Infection Product Offered
11.13.3 Janssen Biopharmaceuticals Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Janssen Biopharmaceuticals Main Business Overview
11.13.5 Janssen Biopharmaceuticals Latest Developments
11.14 Antios Therapeutics, Inc.
11.14.1 Antios Therapeutics, Inc. Company Information
11.14.2 Antios Therapeutics, Inc. Hepatitis Delta Virus (HDV) Infection Product Offered
11.14.3 Antios Therapeutics, Inc. Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Antios Therapeutics, Inc. Main Business Overview
11.14.5 Antios Therapeutics, Inc. Latest Developments
11.15 PharmaEssentia Corporation
11.15.1 PharmaEssentia Corporation Company Information
11.15.2 PharmaEssentia Corporation Hepatitis Delta Virus (HDV) Infection Product Offered
11.15.3 PharmaEssentia Corporation Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 PharmaEssentia Corporation Main Business Overview
11.15.5 PharmaEssentia Corporation Latest Developments
11.16 Replicor, Janssen Pharmaceuticals, Inc
11.16.1 Replicor, Janssen Pharmaceuticals, Inc Company Information
11.16.2 Replicor, Janssen Pharmaceuticals, Inc Hepatitis Delta Virus (HDV) Infection Product Offered
11.16.3 Replicor, Janssen Pharmaceuticals, Inc Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Replicor, Janssen Pharmaceuticals, Inc Main Business Overview
11.16.5 Replicor, Janssen Pharmaceuticals, Inc Latest Developments
11.17 Apotex Corp.
11.17.1 Apotex Corp. Company Information
11.17.2 Apotex Corp. Hepatitis Delta Virus (HDV) Infection Product Offered
11.17.3 Apotex Corp. Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Apotex Corp. Main Business Overview
11.17.5 Apotex Corp. Latest Developments
11.18 Mylan N.V
11.18.1 Mylan N.V Company Information
11.18.2 Mylan N.V Hepatitis Delta Virus (HDV) Infection Product Offered
11.18.3 Mylan N.V Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Mylan N.V Main Business Overview
11.18.5 Mylan N.V Latest Developments
11.19 Aurobindo Pharma Limited
11.19.1 Aurobindo Pharma Limited Company Information
11.19.2 Aurobindo Pharma Limited Hepatitis Delta Virus (HDV) Infection Product Offered
11.19.3 Aurobindo Pharma Limited Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Aurobindo Pharma Limited Main Business Overview
11.19.5 Aurobindo Pharma Limited Latest Developments
11.20 Gilead Sciences, Inc.
11.20.1 Gilead Sciences, Inc. Company Information
11.20.2 Gilead Sciences, Inc. Hepatitis Delta Virus (HDV) Infection Product Offered
11.20.3 Gilead Sciences, Inc. Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Gilead Sciences, Inc. Main Business Overview
11.20.5 Gilead Sciences, Inc. Latest Developments
11.21 GlaxoSmithKline
11.21.1 GlaxoSmithKline Company Information
11.21.2 GlaxoSmithKline Hepatitis Delta Virus (HDV) Infection Product Offered
11.21.3 GlaxoSmithKline Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 GlaxoSmithKline Main Business Overview
11.21.5 GlaxoSmithKline Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hepatitis Delta Virus (HDV) Infection Market Size (2021-2032)
2.1.2 Hepatitis Delta Virus (HDV) Infection Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Hepatitis Delta Virus (HDV) Infection by Country/Region (2021, 2025 & 2032)
2.2 Hepatitis Delta Virus (HDV) Infection Segment by Type
2.2.1 Acute Hepatitis D
2.2.2 Chronic Hepatitis D
2.2.3 Hepatitis Delta Virus (HDV) Infection Market Size by Type
2.2.3.1 Hepatitis Delta Virus (HDV) Infection Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Type (2021-2026)
2.3 Hepatitis Delta Virus (HDV) Infection Segment by Application
2.3.1 Clinic
2.3.2 Hospital
2.3.3 Others
2.3.4 Hepatitis Delta Virus (HDV) Infection Market Size by Application
2.3.4.1 Hepatitis Delta Virus (HDV) Infection Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Application (2021-2026)
3 HEPATITIS DELTA VIRUS (HDV) INFECTION MARKET SIZE BY PLAYER
3.1 Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Player
3.1.1 Global Hepatitis Delta Virus (HDV) Infection Revenue by Player (2021-2026)
3.1.2 Global Hepatitis Delta Virus (HDV) Infection Revenue Market Share by Player (2021-2026)
3.2 Global Hepatitis Delta Virus (HDV) Infection Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HEPATITIS DELTA VIRUS (HDV) INFECTION BY REGION
4.1 Hepatitis Delta Virus (HDV) Infection Market Size by Region (2021-2026)
4.2 Global Hepatitis Delta Virus (HDV) Infection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Hepatitis Delta Virus (HDV) Infection Market Size Growth (2021-2026)
4.4 APAC Hepatitis Delta Virus (HDV) Infection Market Size Growth (2021-2026)
4.5 Europe Hepatitis Delta Virus (HDV) Infection Market Size Growth (2021-2026)
4.6 Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Hepatitis Delta Virus (HDV) Infection Market Size by Country (2021-2026)
5.2 Americas Hepatitis Delta Virus (HDV) Infection Market Size by Type (2021-2026)
5.3 Americas Hepatitis Delta Virus (HDV) Infection Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hepatitis Delta Virus (HDV) Infection Market Size by Region (2021-2026)
6.2 APAC Hepatitis Delta Virus (HDV) Infection Market Size by Type (2021-2026)
6.3 APAC Hepatitis Delta Virus (HDV) Infection Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Hepatitis Delta Virus (HDV) Infection Market Size by Country (2021-2026)
7.2 Europe Hepatitis Delta Virus (HDV) Infection Market Size by Type (2021-2026)
7.3 Europe Hepatitis Delta Virus (HDV) Infection Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hepatitis Delta Virus (HDV) Infection by Region (2021-2026)
8.2 Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size by Type (2021-2026)
8.3 Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HEPATITIS DELTA VIRUS (HDV) INFECTION MARKET FORECAST
10.1 Global Hepatitis Delta Virus (HDV) Infection Forecast by Region (2027-2032)
10.1.1 Global Hepatitis Delta Virus (HDV) Infection Forecast by Region (2027-2032)
10.1.2 Americas Hepatitis Delta Virus (HDV) Infection Forecast
10.1.3 APAC Hepatitis Delta Virus (HDV) Infection Forecast
10.1.4 Europe Hepatitis Delta Virus (HDV) Infection Forecast
10.1.5 Middle East & Africa Hepatitis Delta Virus (HDV) Infection Forecast
10.2 Americas Hepatitis Delta Virus (HDV) Infection Forecast by Country (2027-2032)
10.2.1 United States Market Hepatitis Delta Virus (HDV) Infection Forecast
10.2.2 Canada Market Hepatitis Delta Virus (HDV) Infection Forecast
10.2.3 Mexico Market Hepatitis Delta Virus (HDV) Infection Forecast
10.2.4 Brazil Market Hepatitis Delta Virus (HDV) Infection Forecast
10.3 APAC Hepatitis Delta Virus (HDV) Infection Forecast by Region (2027-2032)
10.3.1 China Hepatitis Delta Virus (HDV) Infection Market Forecast
10.3.2 Japan Market Hepatitis Delta Virus (HDV) Infection Forecast
10.3.3 Korea Market Hepatitis Delta Virus (HDV) Infection Forecast
10.3.4 Southeast Asia Market Hepatitis Delta Virus (HDV) Infection Forecast
10.3.5 India Market Hepatitis Delta Virus (HDV) Infection Forecast
10.3.6 Australia Market Hepatitis Delta Virus (HDV) Infection Forecast
10.4 Europe Hepatitis Delta Virus (HDV) Infection Forecast by Country (2027-2032)
10.4.1 Germany Market Hepatitis Delta Virus (HDV) Infection Forecast
10.4.2 France Market Hepatitis Delta Virus (HDV) Infection Forecast
10.4.3 UK Market Hepatitis Delta Virus (HDV) Infection Forecast
10.4.4 Italy Market Hepatitis Delta Virus (HDV) Infection Forecast
10.4.5 Russia Market Hepatitis Delta Virus (HDV) Infection Forecast
10.5 Middle East & Africa Hepatitis Delta Virus (HDV) Infection Forecast by Region (2027-2032)
10.5.1 Egypt Market Hepatitis Delta Virus (HDV) Infection Forecast
10.5.2 South Africa Market Hepatitis Delta Virus (HDV) Infection Forecast
10.5.3 Israel Market Hepatitis Delta Virus (HDV) Infection Forecast
10.5.4 Turkey Market Hepatitis Delta Virus (HDV) Infection Forecast
10.6 Global Hepatitis Delta Virus (HDV) Infection Forecast by Type (2027-2032)
10.7 Global Hepatitis Delta Virus (HDV) Infection Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Hepatitis Delta Virus (HDV) Infection Forecast
11 KEY PLAYERS ANALYSIS
11.1 BIOSIDUS
11.1.1 BIOSIDUS Company Information
11.1.2 BIOSIDUS Hepatitis Delta Virus (HDV) Infection Product Offered
11.1.3 BIOSIDUS Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 BIOSIDUS Main Business Overview
11.1.5 BIOSIDUS Latest Developments
11.2 Hoffmann-La Roche Ltd.
11.2.1 Hoffmann-La Roche Ltd. Company Information
11.2.2 Hoffmann-La Roche Ltd. Hepatitis Delta Virus (HDV) Infection Product Offered
11.2.3 Hoffmann-La Roche Ltd. Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Hoffmann-La Roche Ltd. Main Business Overview
11.2.5 Hoffmann-La Roche Ltd. Latest Developments
11.3 Zydus Cadila
11.3.1 Zydus Cadila Company Information
11.3.2 Zydus Cadila Hepatitis Delta Virus (HDV) Infection Product Offered
11.3.3 Zydus Cadila Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Zydus Cadila Main Business Overview
11.3.5 Zydus Cadila Latest Developments
11.4 NanoGen Healthcare Pvt. Ltd.
11.4.1 NanoGen Healthcare Pvt. Ltd. Company Information
11.4.2 NanoGen Healthcare Pvt. Ltd. Hepatitis Delta Virus (HDV) Infection Product Offered
11.4.3 NanoGen Healthcare Pvt. Ltd. Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 NanoGen Healthcare Pvt. Ltd. Main Business Overview
11.4.5 NanoGen Healthcare Pvt. Ltd. Latest Developments
11.5 AMEGA Biotech
11.5.1 AMEGA Biotech Company Information
11.5.2 AMEGA Biotech Hepatitis Delta Virus (HDV) Infection Product Offered
11.5.3 AMEGA Biotech Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 AMEGA Biotech Main Business Overview
11.5.5 AMEGA Biotech Latest Developments
11.6 Rhein-Minapharm
11.6.1 Rhein-Minapharm Company Information
11.6.2 Rhein-Minapharm Hepatitis Delta Virus (HDV) Infection Product Offered
11.6.3 Rhein-Minapharm Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Rhein-Minapharm Main Business Overview
11.6.5 Rhein-Minapharm Latest Developments
11.7 PROBIOMED SA de CV
11.7.1 PROBIOMED SA de CV Company Information
11.7.2 PROBIOMED SA de CV Hepatitis Delta Virus (HDV) Infection Product Offered
11.7.3 PROBIOMED SA de CV Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 PROBIOMED SA de CV Main Business Overview
11.7.5 PROBIOMED SA de CV Latest Developments
11.8 3SBio Group
11.8.1 3SBio Group Company Information
11.8.2 3SBio Group Hepatitis Delta Virus (HDV) Infection Product Offered
11.8.3 3SBio Group Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 3SBio Group Main Business Overview
11.8.5 3SBio Group Latest Developments
11.9 Eiger BioPharmaceuticals
11.9.1 Eiger BioPharmaceuticals Company Information
11.9.2 Eiger BioPharmaceuticals Hepatitis Delta Virus (HDV) Infection Product Offered
11.9.3 Eiger BioPharmaceuticals Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Eiger BioPharmaceuticals Main Business Overview
11.9.5 Eiger BioPharmaceuticals Latest Developments
11.10 Arrowhead Pharmaceuticals, Inc
11.10.1 Arrowhead Pharmaceuticals, Inc Company Information
11.10.2 Arrowhead Pharmaceuticals, Inc Hepatitis Delta Virus (HDV) Infection Product Offered
11.10.3 Arrowhead Pharmaceuticals, Inc Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Arrowhead Pharmaceuticals, Inc Main Business Overview
11.10.5 Arrowhead Pharmaceuticals, Inc Latest Developments
11.11 MYR Pharmaceuticals
11.11.1 MYR Pharmaceuticals Company Information
11.11.2 MYR Pharmaceuticals Hepatitis Delta Virus (HDV) Infection Product Offered
11.11.3 MYR Pharmaceuticals Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 MYR Pharmaceuticals Main Business Overview
11.11.5 MYR Pharmaceuticals Latest Developments
11.12 Hepatera
11.12.1 Hepatera Company Information
11.12.2 Hepatera Hepatitis Delta Virus (HDV) Infection Product Offered
11.12.3 Hepatera Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Hepatera Main Business Overview
11.12.5 Hepatera Latest Developments
11.13 Janssen Biopharmaceuticals
11.13.1 Janssen Biopharmaceuticals Company Information
11.13.2 Janssen Biopharmaceuticals Hepatitis Delta Virus (HDV) Infection Product Offered
11.13.3 Janssen Biopharmaceuticals Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Janssen Biopharmaceuticals Main Business Overview
11.13.5 Janssen Biopharmaceuticals Latest Developments
11.14 Antios Therapeutics, Inc.
11.14.1 Antios Therapeutics, Inc. Company Information
11.14.2 Antios Therapeutics, Inc. Hepatitis Delta Virus (HDV) Infection Product Offered
11.14.3 Antios Therapeutics, Inc. Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Antios Therapeutics, Inc. Main Business Overview
11.14.5 Antios Therapeutics, Inc. Latest Developments
11.15 PharmaEssentia Corporation
11.15.1 PharmaEssentia Corporation Company Information
11.15.2 PharmaEssentia Corporation Hepatitis Delta Virus (HDV) Infection Product Offered
11.15.3 PharmaEssentia Corporation Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 PharmaEssentia Corporation Main Business Overview
11.15.5 PharmaEssentia Corporation Latest Developments
11.16 Replicor, Janssen Pharmaceuticals, Inc
11.16.1 Replicor, Janssen Pharmaceuticals, Inc Company Information
11.16.2 Replicor, Janssen Pharmaceuticals, Inc Hepatitis Delta Virus (HDV) Infection Product Offered
11.16.3 Replicor, Janssen Pharmaceuticals, Inc Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Replicor, Janssen Pharmaceuticals, Inc Main Business Overview
11.16.5 Replicor, Janssen Pharmaceuticals, Inc Latest Developments
11.17 Apotex Corp.
11.17.1 Apotex Corp. Company Information
11.17.2 Apotex Corp. Hepatitis Delta Virus (HDV) Infection Product Offered
11.17.3 Apotex Corp. Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Apotex Corp. Main Business Overview
11.17.5 Apotex Corp. Latest Developments
11.18 Mylan N.V
11.18.1 Mylan N.V Company Information
11.18.2 Mylan N.V Hepatitis Delta Virus (HDV) Infection Product Offered
11.18.3 Mylan N.V Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Mylan N.V Main Business Overview
11.18.5 Mylan N.V Latest Developments
11.19 Aurobindo Pharma Limited
11.19.1 Aurobindo Pharma Limited Company Information
11.19.2 Aurobindo Pharma Limited Hepatitis Delta Virus (HDV) Infection Product Offered
11.19.3 Aurobindo Pharma Limited Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Aurobindo Pharma Limited Main Business Overview
11.19.5 Aurobindo Pharma Limited Latest Developments
11.20 Gilead Sciences, Inc.
11.20.1 Gilead Sciences, Inc. Company Information
11.20.2 Gilead Sciences, Inc. Hepatitis Delta Virus (HDV) Infection Product Offered
11.20.3 Gilead Sciences, Inc. Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Gilead Sciences, Inc. Main Business Overview
11.20.5 Gilead Sciences, Inc. Latest Developments
11.21 GlaxoSmithKline
11.21.1 GlaxoSmithKline Company Information
11.21.2 GlaxoSmithKline Hepatitis Delta Virus (HDV) Infection Product Offered
11.21.3 GlaxoSmithKline Hepatitis Delta Virus (HDV) Infection Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 GlaxoSmithKline Main Business Overview
11.21.5 GlaxoSmithKline Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Hepatitis Delta Virus (HDV) Infection Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Hepatitis Delta Virus (HDV) Infection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Acute Hepatitis D
Table 4. Major Players of Chronic Hepatitis D
Table 5. Hepatitis Delta Virus (HDV) Infection Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Hepatitis Delta Virus (HDV) Infection Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Type (2021-2026)
Table 8. Hepatitis Delta Virus (HDV) Infection Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Hepatitis Delta Virus (HDV) Infection Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Application (2021-2026)
Table 11. Global Hepatitis Delta Virus (HDV) Infection Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Hepatitis Delta Virus (HDV) Infection Revenue Market Share by Player (2021-2026)
Table 13. Hepatitis Delta Virus (HDV) Infection Key Players Head office and Products Offered
Table 14. Hepatitis Delta Virus (HDV) Infection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Hepatitis Delta Virus (HDV) Infection Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Region (2021-2026)
Table 19. Global Hepatitis Delta Virus (HDV) Infection Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Hepatitis Delta Virus (HDV) Infection Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Hepatitis Delta Virus (HDV) Infection Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Country (2021-2026)
Table 23. Americas Hepatitis Delta Virus (HDV) Infection Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Type (2021-2026)
Table 25. Americas Hepatitis Delta Virus (HDV) Infection Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Application (2021-2026)
Table 27. APAC Hepatitis Delta Virus (HDV) Infection Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Region (2021-2026)
Table 29. APAC Hepatitis Delta Virus (HDV) Infection Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Hepatitis Delta Virus (HDV) Infection Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Hepatitis Delta Virus (HDV) Infection Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Country (2021-2026)
Table 33. Europe Hepatitis Delta Virus (HDV) Infection Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Hepatitis Delta Virus (HDV) Infection Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Hepatitis Delta Virus (HDV) Infection
Table 39. Key Market Challenges & Risks of Hepatitis Delta Virus (HDV) Infection
Table 40. Key Industry Trends of Hepatitis Delta Virus (HDV) Infection
Table 41. Global Hepatitis Delta Virus (HDV) Infection Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Hepatitis Delta Virus (HDV) Infection Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Hepatitis Delta Virus (HDV) Infection Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Hepatitis Delta Virus (HDV) Infection Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. BIOSIDUS Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 46. BIOSIDUS Hepatitis Delta Virus (HDV) Infection Product Offered
Table 47. BIOSIDUS Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. BIOSIDUS Main Business
Table 49. BIOSIDUS Latest Developments
Table 50. Hoffmann-La Roche Ltd. Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 51. Hoffmann-La Roche Ltd. Hepatitis Delta Virus (HDV) Infection Product Offered
Table 52. Hoffmann-La Roche Ltd. Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Hoffmann-La Roche Ltd. Main Business
Table 54. Hoffmann-La Roche Ltd. Latest Developments
Table 55. Zydus Cadila Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 56. Zydus Cadila Hepatitis Delta Virus (HDV) Infection Product Offered
Table 57. Zydus Cadila Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Zydus Cadila Main Business
Table 59. Zydus Cadila Latest Developments
Table 60. NanoGen Healthcare Pvt. Ltd. Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 61. NanoGen Healthcare Pvt. Ltd. Hepatitis Delta Virus (HDV) Infection Product Offered
Table 62. NanoGen Healthcare Pvt. Ltd. Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. NanoGen Healthcare Pvt. Ltd. Main Business
Table 64. NanoGen Healthcare Pvt. Ltd. Latest Developments
Table 65. AMEGA Biotech Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 66. AMEGA Biotech Hepatitis Delta Virus (HDV) Infection Product Offered
Table 67. AMEGA Biotech Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. AMEGA Biotech Main Business
Table 69. AMEGA Biotech Latest Developments
Table 70. Rhein-Minapharm Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 71. Rhein-Minapharm Hepatitis Delta Virus (HDV) Infection Product Offered
Table 72. Rhein-Minapharm Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Rhein-Minapharm Main Business
Table 74. Rhein-Minapharm Latest Developments
Table 75. PROBIOMED SA de CV Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 76. PROBIOMED SA de CV Hepatitis Delta Virus (HDV) Infection Product Offered
Table 77. PROBIOMED SA de CV Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. PROBIOMED SA de CV Main Business
Table 79. PROBIOMED SA de CV Latest Developments
Table 80. 3SBio Group Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 81. 3SBio Group Hepatitis Delta Virus (HDV) Infection Product Offered
Table 82. 3SBio Group Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. 3SBio Group Main Business
Table 84. 3SBio Group Latest Developments
Table 85. Eiger BioPharmaceuticals Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 86. Eiger BioPharmaceuticals Hepatitis Delta Virus (HDV) Infection Product Offered
Table 87. Eiger BioPharmaceuticals Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Eiger BioPharmaceuticals Main Business
Table 89. Eiger BioPharmaceuticals Latest Developments
Table 90. Arrowhead Pharmaceuticals, Inc Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 91. Arrowhead Pharmaceuticals, Inc Hepatitis Delta Virus (HDV) Infection Product Offered
Table 92. Arrowhead Pharmaceuticals, Inc Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Arrowhead Pharmaceuticals, Inc Main Business
Table 94. Arrowhead Pharmaceuticals, Inc Latest Developments
Table 95. MYR Pharmaceuticals Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 96. MYR Pharmaceuticals Hepatitis Delta Virus (HDV) Infection Product Offered
Table 97. MYR Pharmaceuticals Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. MYR Pharmaceuticals Main Business
Table 99. MYR Pharmaceuticals Latest Developments
Table 100. Hepatera Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 101. Hepatera Hepatitis Delta Virus (HDV) Infection Product Offered
Table 102. Hepatera Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Hepatera Main Business
Table 104. Hepatera Latest Developments
Table 105. Janssen Biopharmaceuticals Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 106. Janssen Biopharmaceuticals Hepatitis Delta Virus (HDV) Infection Product Offered
Table 107. Janssen Biopharmaceuticals Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Janssen Biopharmaceuticals Main Business
Table 109. Janssen Biopharmaceuticals Latest Developments
Table 110. Antios Therapeutics, Inc. Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 111. Antios Therapeutics, Inc. Hepatitis Delta Virus (HDV) Infection Product Offered
Table 112. Antios Therapeutics, Inc. Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Antios Therapeutics, Inc. Main Business
Table 114. Antios Therapeutics, Inc. Latest Developments
Table 115. PharmaEssentia Corporation Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 116. PharmaEssentia Corporation Hepatitis Delta Virus (HDV) Infection Product Offered
Table 117. PharmaEssentia Corporation Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. PharmaEssentia Corporation Main Business
Table 119. PharmaEssentia Corporation Latest Developments
Table 120. Replicor, Janssen Pharmaceuticals, Inc Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 121. Replicor, Janssen Pharmaceuticals, Inc Hepatitis Delta Virus (HDV) Infection Product Offered
Table 122. Replicor, Janssen Pharmaceuticals, Inc Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Replicor, Janssen Pharmaceuticals, Inc Main Business
Table 124. Replicor, Janssen Pharmaceuticals, Inc Latest Developments
Table 125. Apotex Corp. Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 126. Apotex Corp. Hepatitis Delta Virus (HDV) Infection Product Offered
Table 127. Apotex Corp. Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Apotex Corp. Main Business
Table 129. Apotex Corp. Latest Developments
Table 130. Mylan N.V Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 131. Mylan N.V Hepatitis Delta Virus (HDV) Infection Product Offered
Table 132. Mylan N.V Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Mylan N.V Main Business
Table 134. Mylan N.V Latest Developments
Table 135. Aurobindo Pharma Limited Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 136. Aurobindo Pharma Limited Hepatitis Delta Virus (HDV) Infection Product Offered
Table 137. Aurobindo Pharma Limited Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Aurobindo Pharma Limited Main Business
Table 139. Aurobindo Pharma Limited Latest Developments
Table 140. Gilead Sciences, Inc. Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 141. Gilead Sciences, Inc. Hepatitis Delta Virus (HDV) Infection Product Offered
Table 142. Gilead Sciences, Inc. Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. Gilead Sciences, Inc. Main Business
Table 144. Gilead Sciences, Inc. Latest Developments
Table 145. GlaxoSmithKline Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 146. GlaxoSmithKline Hepatitis Delta Virus (HDV) Infection Product Offered
Table 147. GlaxoSmithKline Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 148. GlaxoSmithKline Main Business
Table 149. GlaxoSmithKline Latest Developments
Table 1. Hepatitis Delta Virus (HDV) Infection Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Hepatitis Delta Virus (HDV) Infection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Acute Hepatitis D
Table 4. Major Players of Chronic Hepatitis D
Table 5. Hepatitis Delta Virus (HDV) Infection Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Hepatitis Delta Virus (HDV) Infection Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Type (2021-2026)
Table 8. Hepatitis Delta Virus (HDV) Infection Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Hepatitis Delta Virus (HDV) Infection Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Application (2021-2026)
Table 11. Global Hepatitis Delta Virus (HDV) Infection Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Hepatitis Delta Virus (HDV) Infection Revenue Market Share by Player (2021-2026)
Table 13. Hepatitis Delta Virus (HDV) Infection Key Players Head office and Products Offered
Table 14. Hepatitis Delta Virus (HDV) Infection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Hepatitis Delta Virus (HDV) Infection Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Region (2021-2026)
Table 19. Global Hepatitis Delta Virus (HDV) Infection Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Hepatitis Delta Virus (HDV) Infection Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Hepatitis Delta Virus (HDV) Infection Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Country (2021-2026)
Table 23. Americas Hepatitis Delta Virus (HDV) Infection Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Type (2021-2026)
Table 25. Americas Hepatitis Delta Virus (HDV) Infection Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Application (2021-2026)
Table 27. APAC Hepatitis Delta Virus (HDV) Infection Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Region (2021-2026)
Table 29. APAC Hepatitis Delta Virus (HDV) Infection Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Hepatitis Delta Virus (HDV) Infection Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Hepatitis Delta Virus (HDV) Infection Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Country (2021-2026)
Table 33. Europe Hepatitis Delta Virus (HDV) Infection Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Hepatitis Delta Virus (HDV) Infection Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Hepatitis Delta Virus (HDV) Infection
Table 39. Key Market Challenges & Risks of Hepatitis Delta Virus (HDV) Infection
Table 40. Key Industry Trends of Hepatitis Delta Virus (HDV) Infection
Table 41. Global Hepatitis Delta Virus (HDV) Infection Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Hepatitis Delta Virus (HDV) Infection Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Hepatitis Delta Virus (HDV) Infection Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Hepatitis Delta Virus (HDV) Infection Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. BIOSIDUS Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 46. BIOSIDUS Hepatitis Delta Virus (HDV) Infection Product Offered
Table 47. BIOSIDUS Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. BIOSIDUS Main Business
Table 49. BIOSIDUS Latest Developments
Table 50. Hoffmann-La Roche Ltd. Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 51. Hoffmann-La Roche Ltd. Hepatitis Delta Virus (HDV) Infection Product Offered
Table 52. Hoffmann-La Roche Ltd. Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Hoffmann-La Roche Ltd. Main Business
Table 54. Hoffmann-La Roche Ltd. Latest Developments
Table 55. Zydus Cadila Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 56. Zydus Cadila Hepatitis Delta Virus (HDV) Infection Product Offered
Table 57. Zydus Cadila Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Zydus Cadila Main Business
Table 59. Zydus Cadila Latest Developments
Table 60. NanoGen Healthcare Pvt. Ltd. Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 61. NanoGen Healthcare Pvt. Ltd. Hepatitis Delta Virus (HDV) Infection Product Offered
Table 62. NanoGen Healthcare Pvt. Ltd. Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. NanoGen Healthcare Pvt. Ltd. Main Business
Table 64. NanoGen Healthcare Pvt. Ltd. Latest Developments
Table 65. AMEGA Biotech Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 66. AMEGA Biotech Hepatitis Delta Virus (HDV) Infection Product Offered
Table 67. AMEGA Biotech Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. AMEGA Biotech Main Business
Table 69. AMEGA Biotech Latest Developments
Table 70. Rhein-Minapharm Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 71. Rhein-Minapharm Hepatitis Delta Virus (HDV) Infection Product Offered
Table 72. Rhein-Minapharm Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Rhein-Minapharm Main Business
Table 74. Rhein-Minapharm Latest Developments
Table 75. PROBIOMED SA de CV Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 76. PROBIOMED SA de CV Hepatitis Delta Virus (HDV) Infection Product Offered
Table 77. PROBIOMED SA de CV Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. PROBIOMED SA de CV Main Business
Table 79. PROBIOMED SA de CV Latest Developments
Table 80. 3SBio Group Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 81. 3SBio Group Hepatitis Delta Virus (HDV) Infection Product Offered
Table 82. 3SBio Group Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. 3SBio Group Main Business
Table 84. 3SBio Group Latest Developments
Table 85. Eiger BioPharmaceuticals Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 86. Eiger BioPharmaceuticals Hepatitis Delta Virus (HDV) Infection Product Offered
Table 87. Eiger BioPharmaceuticals Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Eiger BioPharmaceuticals Main Business
Table 89. Eiger BioPharmaceuticals Latest Developments
Table 90. Arrowhead Pharmaceuticals, Inc Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 91. Arrowhead Pharmaceuticals, Inc Hepatitis Delta Virus (HDV) Infection Product Offered
Table 92. Arrowhead Pharmaceuticals, Inc Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Arrowhead Pharmaceuticals, Inc Main Business
Table 94. Arrowhead Pharmaceuticals, Inc Latest Developments
Table 95. MYR Pharmaceuticals Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 96. MYR Pharmaceuticals Hepatitis Delta Virus (HDV) Infection Product Offered
Table 97. MYR Pharmaceuticals Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. MYR Pharmaceuticals Main Business
Table 99. MYR Pharmaceuticals Latest Developments
Table 100. Hepatera Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 101. Hepatera Hepatitis Delta Virus (HDV) Infection Product Offered
Table 102. Hepatera Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Hepatera Main Business
Table 104. Hepatera Latest Developments
Table 105. Janssen Biopharmaceuticals Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 106. Janssen Biopharmaceuticals Hepatitis Delta Virus (HDV) Infection Product Offered
Table 107. Janssen Biopharmaceuticals Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Janssen Biopharmaceuticals Main Business
Table 109. Janssen Biopharmaceuticals Latest Developments
Table 110. Antios Therapeutics, Inc. Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 111. Antios Therapeutics, Inc. Hepatitis Delta Virus (HDV) Infection Product Offered
Table 112. Antios Therapeutics, Inc. Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Antios Therapeutics, Inc. Main Business
Table 114. Antios Therapeutics, Inc. Latest Developments
Table 115. PharmaEssentia Corporation Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 116. PharmaEssentia Corporation Hepatitis Delta Virus (HDV) Infection Product Offered
Table 117. PharmaEssentia Corporation Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. PharmaEssentia Corporation Main Business
Table 119. PharmaEssentia Corporation Latest Developments
Table 120. Replicor, Janssen Pharmaceuticals, Inc Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 121. Replicor, Janssen Pharmaceuticals, Inc Hepatitis Delta Virus (HDV) Infection Product Offered
Table 122. Replicor, Janssen Pharmaceuticals, Inc Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Replicor, Janssen Pharmaceuticals, Inc Main Business
Table 124. Replicor, Janssen Pharmaceuticals, Inc Latest Developments
Table 125. Apotex Corp. Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 126. Apotex Corp. Hepatitis Delta Virus (HDV) Infection Product Offered
Table 127. Apotex Corp. Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Apotex Corp. Main Business
Table 129. Apotex Corp. Latest Developments
Table 130. Mylan N.V Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 131. Mylan N.V Hepatitis Delta Virus (HDV) Infection Product Offered
Table 132. Mylan N.V Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Mylan N.V Main Business
Table 134. Mylan N.V Latest Developments
Table 135. Aurobindo Pharma Limited Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 136. Aurobindo Pharma Limited Hepatitis Delta Virus (HDV) Infection Product Offered
Table 137. Aurobindo Pharma Limited Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Aurobindo Pharma Limited Main Business
Table 139. Aurobindo Pharma Limited Latest Developments
Table 140. Gilead Sciences, Inc. Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 141. Gilead Sciences, Inc. Hepatitis Delta Virus (HDV) Infection Product Offered
Table 142. Gilead Sciences, Inc. Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. Gilead Sciences, Inc. Main Business
Table 144. Gilead Sciences, Inc. Latest Developments
Table 145. GlaxoSmithKline Details, Company Type, Hepatitis Delta Virus (HDV) Infection Area Served and Its Competitors
Table 146. GlaxoSmithKline Hepatitis Delta Virus (HDV) Infection Product Offered
Table 147. GlaxoSmithKline Hepatitis Delta Virus (HDV) Infection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 148. GlaxoSmithKline Main Business
Table 149. GlaxoSmithKline Latest Developments
LIST OF FIGURES
Figure 1. Hepatitis Delta Virus (HDV) Infection Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hepatitis Delta Virus (HDV) Infection Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Hepatitis Delta Virus (HDV) Infection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Hepatitis Delta Virus (HDV) Infection Sales Market Share by Country/Region (2025)
Figure 8. Hepatitis Delta Virus (HDV) Infection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Type in 2025
Figure 10. Hepatitis Delta Virus (HDV) Infection in Clinic
Figure 11. Global Hepatitis Delta Virus (HDV) Infection Market: Clinic (2021-2026) & ($ millions)
Figure 12. Hepatitis Delta Virus (HDV) Infection in Hospital
Figure 13. Global Hepatitis Delta Virus (HDV) Infection Market: Hospital (2021-2026) & ($ millions)
Figure 14. Hepatitis Delta Virus (HDV) Infection in Others
Figure 15. Global Hepatitis Delta Virus (HDV) Infection Market: Others (2021-2026) & ($ millions)
Figure 16. Global Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Application in 2025
Figure 17. Global Hepatitis Delta Virus (HDV) Infection Revenue Market Share by Player in 2025
Figure 18. Global Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Region (2021-2026)
Figure 19. Americas Hepatitis Delta Virus (HDV) Infection Market Size 2021-2026 ($ millions)
Figure 20. APAC Hepatitis Delta Virus (HDV) Infection Market Size 2021-2026 ($ millions)
Figure 21. Europe Hepatitis Delta Virus (HDV) Infection Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size 2021-2026 ($ millions)
Figure 23. Americas Hepatitis Delta Virus (HDV) Infection Value Market Share by Country in 2025
Figure 24. United States Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Region in 2025
Figure 29. APAC Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Type (2021-2026)
Figure 30. APAC Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Application (2021-2026)
Figure 31. China Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 35. India Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Country in 2025
Figure 38. Europe Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Type (2021-2026)
Figure 39. Europe Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Application (2021-2026)
Figure 40. Germany Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 41. France Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 54. APAC Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 55. Europe Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 57. United States Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 58. Canada Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 59. Mexico Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 60. Brazil Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 61. China Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 62. Japan Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 63. Korea Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 65. India Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 66. Australia Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 67. Germany Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 68. France Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 69. UK Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 70. Italy Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 71. Russia Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 72. Egypt Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 73. South Africa Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 74. Israel Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 75. Turkey Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 76. Global Hepatitis Delta Virus (HDV) Infection Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Hepatitis Delta Virus (HDV) Infection Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 1. Hepatitis Delta Virus (HDV) Infection Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hepatitis Delta Virus (HDV) Infection Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Hepatitis Delta Virus (HDV) Infection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Hepatitis Delta Virus (HDV) Infection Sales Market Share by Country/Region (2025)
Figure 8. Hepatitis Delta Virus (HDV) Infection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Type in 2025
Figure 10. Hepatitis Delta Virus (HDV) Infection in Clinic
Figure 11. Global Hepatitis Delta Virus (HDV) Infection Market: Clinic (2021-2026) & ($ millions)
Figure 12. Hepatitis Delta Virus (HDV) Infection in Hospital
Figure 13. Global Hepatitis Delta Virus (HDV) Infection Market: Hospital (2021-2026) & ($ millions)
Figure 14. Hepatitis Delta Virus (HDV) Infection in Others
Figure 15. Global Hepatitis Delta Virus (HDV) Infection Market: Others (2021-2026) & ($ millions)
Figure 16. Global Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Application in 2025
Figure 17. Global Hepatitis Delta Virus (HDV) Infection Revenue Market Share by Player in 2025
Figure 18. Global Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Region (2021-2026)
Figure 19. Americas Hepatitis Delta Virus (HDV) Infection Market Size 2021-2026 ($ millions)
Figure 20. APAC Hepatitis Delta Virus (HDV) Infection Market Size 2021-2026 ($ millions)
Figure 21. Europe Hepatitis Delta Virus (HDV) Infection Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size 2021-2026 ($ millions)
Figure 23. Americas Hepatitis Delta Virus (HDV) Infection Value Market Share by Country in 2025
Figure 24. United States Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Region in 2025
Figure 29. APAC Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Type (2021-2026)
Figure 30. APAC Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Application (2021-2026)
Figure 31. China Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 35. India Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Country in 2025
Figure 38. Europe Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Type (2021-2026)
Figure 39. Europe Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Application (2021-2026)
Figure 40. Germany Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 41. France Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Hepatitis Delta Virus (HDV) Infection Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 54. APAC Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 55. Europe Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 57. United States Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 58. Canada Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 59. Mexico Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 60. Brazil Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 61. China Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 62. Japan Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 63. Korea Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 65. India Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 66. Australia Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 67. Germany Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 68. France Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 69. UK Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 70. Italy Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 71. Russia Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 72. Egypt Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 73. South Africa Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 74. Israel Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 75. Turkey Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
Figure 76. Global Hepatitis Delta Virus (HDV) Infection Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Hepatitis Delta Virus (HDV) Infection Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Hepatitis Delta Virus (HDV) Infection Market Size 2027-2032 ($ millions)
